Sweden has a strong tradition in brain tumor research that is well funded primarily through the Cancer Foundation and the Childhood Cancer Foundation, but new approaches are needed. At the intersection of experimental and clinical research, new ideas can emerge and be tested. A prerequisite for this is that clinicians and basic researchers meet to exchange hypotheses and share experiences to a greater extent than everyday life usually allows, especially for people who work in healthcare. With this as a starting point, Mattias Belting and co-workers gathered neuro-oncology researchers from Lund and Uppsala for a joint meeting during two September days in Arild. The meeting brought together about 40 participants from research groups in clinical oncology, neurosurgery, tumor microenvironment, basic tumor biology, advanced proteomics and immunotherapy.

Check full text here (in swedish):